acetyl-dl-leucine has been researched along with Ataxia in 3 studies
acetylleucine: used for treating vestibular-related imbalance and vertigo
Ataxia: Impairment of the ability to perform smoothly coordinated voluntary movements. This condition may affect the limbs, trunk, eyes, pharynx, larynx, and other structures. Ataxia may result from impaired sensory or motor function. Sensory ataxia may result from posterior column injury or PERIPHERAL NERVE DISEASES. Motor ataxia may be associated with CEREBELLAR DISEASES; CEREBRAL CORTEX diseases; THALAMIC DISEASES; BASAL GANGLIA DISEASES; injury to the RED NUCLEUS; and other conditions.
| Excerpt | Relevance | Reference |
|---|---|---|
| " NALL was safe and well tolerated, contributing to an overall favorable risk:benefit profile." | 3.30 | Efficacy and Safety of N-Acetyl-l-Leucine in Children and Adults With GM2 Gangliosidoses. ( Bremova-Ertl, T; Claassen, J; Gascon-Bayari, J; Goldschagg, N; Hahn, A; Hassan, A; Hennig, A; Jones, S; Kay, R; Lau, H; Martakis, K; Perlman, S; Schneider, S; Sharma, R, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Becker-Bense, S | 1 |
| Kaiser, L | 1 |
| Becker, R | 1 |
| Feil, K | 1 |
| Muth, C | 1 |
| Albert, NL | 1 |
| Unterrainer, M | 1 |
| Bartenstein, P | 1 |
| Strupp, M | 1 |
| Dieterich, M | 1 |
| Martakis, K | 3 |
| Claassen, J | 3 |
| Gascon-Bayari, J | 3 |
| Goldschagg, N | 3 |
| Hahn, A | 3 |
| Hassan, A | 3 |
| Hennig, A | 3 |
| Jones, S | 3 |
| Kay, R | 3 |
| Lau, H | 3 |
| Perlman, S | 3 |
| Sharma, R | 3 |
| Schneider, S | 3 |
| Bremova-Ertl, T | 3 |
| Saberi-Karimian, M | 2 |
| Houra, M | 2 |
| Jamialahmadi, T | 2 |
| Sarvghadi, P | 2 |
| Nikbaf, M | 2 |
| Akhlaghi, S | 2 |
| Sahebkar, A | 2 |
1 trial available for acetyl-dl-leucine and Ataxia
| Article | Year |
|---|---|
Efficacy and Safety of N-Acetyl-l-Leucine in Children and Adults With GM2 Gangliosidoses.
Topics: Adolescent; Adult; Ataxia; Child; Female; Gangliosidoses, GM2; Humans; Male; Middle Aged; Quality of | 2023 |
Efficacy and Safety of N-Acetyl-l-Leucine in Children and Adults With GM2 Gangliosidoses.
Topics: Adolescent; Adult; Ataxia; Child; Female; Gangliosidoses, GM2; Humans; Male; Middle Aged; Quality of | 2023 |
Efficacy and Safety of N-Acetyl-l-Leucine in Children and Adults With GM2 Gangliosidoses.
Topics: Adolescent; Adult; Ataxia; Child; Female; Gangliosidoses, GM2; Humans; Male; Middle Aged; Quality of | 2023 |
Efficacy and Safety of N-Acetyl-l-Leucine in Children and Adults With GM2 Gangliosidoses.
Topics: Adolescent; Adult; Ataxia; Child; Female; Gangliosidoses, GM2; Humans; Male; Middle Aged; Quality of | 2023 |
2 other studies available for acetyl-dl-leucine and Ataxia
| Article | Year |
|---|---|
Acetyl-DL-leucine in cerebellar ataxia ([
Topics: Ataxia; Cerebellar Ataxia; Fluorodeoxyglucose F18; Humans; Quality of Life; Retrospective Studies | 2023 |
The Effects of N-Acetyl-L-Leucine on the Improvement of Symptoms in a Patient with Multiple Sulfatase Deficiency.
Topics: Ataxia; Cerebellar Ataxia; Child; Female; Humans; Interleukin-6; Multiple Sulfatase Deficiency Disea | 2023 |
The Effects of N-Acetyl-L-Leucine on the Improvement of Symptoms in a Patient with Multiple Sulfatase Deficiency.
Topics: Ataxia; Cerebellar Ataxia; Child; Female; Humans; Interleukin-6; Multiple Sulfatase Deficiency Disea | 2023 |
The Effects of N-Acetyl-L-Leucine on the Improvement of Symptoms in a Patient with Multiple Sulfatase Deficiency.
Topics: Ataxia; Cerebellar Ataxia; Child; Female; Humans; Interleukin-6; Multiple Sulfatase Deficiency Disea | 2023 |
The Effects of N-Acetyl-L-Leucine on the Improvement of Symptoms in a Patient with Multiple Sulfatase Deficiency.
Topics: Ataxia; Cerebellar Ataxia; Child; Female; Humans; Interleukin-6; Multiple Sulfatase Deficiency Disea | 2023 |